Group leader
Christina Zielinski studied medicine at the University of Heidelberg (Germany), at Harvard University (USA) and Duke University (USA). Her MD thesis research was performed at Yale University as a scholar of the German National Merit Foundation where she focused on the role of T cells in the pathogenesis of lupus erythematosus. Christina performed her postdoctoral training as a scholar of the German Research Foundation in the lab of Federica Sallusto in Switzerland where she deciphered the regulatory cues that drive distinct functionalities of human Th17 cells. She then started her own research group as a clinical scientist at the Department of Dermatology at the Charité University Hospital in Berlin.
Christina also completed her clinical specialization in dermatology and allergology at the University of Tübingen and the Charité in Berlin. In 2015, Christina was appointed professor at the German Center for Infection Research at the Technical University of Munich. Since 2021, she has been the Chair of Infection Immunology at the Leibniz Institute for Natural Product Research and Infection Biology and the Friedrich Schiller University in Jena, where she continues to work on the regulation of human T cells and their translational impact in autoimmunity, infections, and cancer. Christina is a mentor for scholars of the German National Merit Foundation. She is, in particular, highly dedicated to the promotion of women in science.
Zielinski Lab 